Boe Sorensen

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (30)

Peter Hokland

Aarhus University

DENMARK

View details

Peter Meldgaard

Assistant Professor

Aarhus University

DENMARK

View details

Lars Aagaard

Aarhus University

DENMARK

View details

Tina Fuglsang Daugaard

Aarhus University

DENMARK

View details

Anders Etzerodt

Aarhus University

DENMARK

View details

Christoffer Trier Månsson

Aarhus University

DENMARK

View details

Clare Puttick

The Francis Crick Institute

UNITED KINGDOM

View details

Johanne Lade-Keller

Aalborg University

DENMARK

View details

Rasmus Bak

Aarhus University

DENMARK

View details

Mikkel Carstensen

Aarhus University

DENMARK

View details

JAMES READING

University College London

UNITED KINGDOM

View details

Anne Grosboel Jensen

Aarhus University

DENMARK

View details

Marie Bill

Aarhus University

DENMARK

View details

Simone Stensgaard

Aarhus University

DENMARK

View details

Yonglun Luo

DENMARK

View details

Eva Holm Greibe

Associate Professor

Aarhus University

DENMARK

View details

Mette Nyegaard

Aalborg University

DENMARK

View details

Johannes Schmid

Aarhus University

DENMARK

View details

Hans Jürgen Hoffmann

Professor

Aarhus Universitet Health

DENMARK

View details

Kristian Wiborg Antonsen

Aarhus University

DENMARK

View details

Signe Neldeborg

Aarhus University

DENMARK

View details

Maja Ludvigsen

Aarhus University

DENMARK

View details

Lene Niemann Nejsum

Aarhus University

DENMARK

View details

Magnus Stougaard

Aarhus University

DENMARK

View details

Søren Kragh Moestrup

Professsor

University of Southern Denmark

DENMARK

View details

Brage Storstein Andresen

Professor

University of Southern Denmark

DENMARK

View details

Emil Aagaard Thomsen

Aarhus University

DENMARK

View details

Anders L. Nielsen

Aarhus University

DENMARK

View details

Zaigham Saghir

Københavns Universitet

DENMARK

View details

Christian Borbjerg Laursen

Odense University Hospital

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Boe Sorensen

Research Interests

Explore related searches

Contact this professor

Articles (26)

Development and validation of an LC-MS/MS method for quantification of Osimertinib and its two metabolites AZ7550 and AZ5104 in human plasma including long-time storage

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures

Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R)

ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach

Clinical and molecular characteristics of 42 Danish patients with metastatic ALK fusion-positive lung cancer treated with first-line alectinib: A nationwide study

In vitro ovarian tumor-conditioned CD163+ human macrophages retain phagocytic response to CD47 blockade

Proinflammatory polarization strongly reduces human macrophage in vitro phagocytosis of tumor cells in response to CD47 blockade

Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes

Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies

A five-gene qPCR signature can classify type 2 asthma comparably to microscopy of induced sputum from severe asthma patients

Expression of the non-coding RNA nc886 facilitates the development of tyrosine kinase inhibitor resistance in EGFR-mutated non-small-cell lung cancer cells

In vitro size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies

In vitro size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies

ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach.

Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo

Cell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients.

Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small cell lung cancer patients.

Examination of the Functional Relationship between PD-L1 DNA Methylation and mRNA Expression in Non-Small-Cell Lung Cancer

Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells

DNAfusion: an R/Bioconductor package for increased sensitivity of detecting gene fusions in liquid biopsies

Comparison of culture media reveals that non-essential amino acids strongly affect the phenotype of human monocyte-derived macrophages

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells

Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor

An Extended PD-L2 Cytoplasmic Domain Results From Alternative Splicing in NSCLC Cells.

An Extended PD-L2 Cytoplasmic Domain Results From Alternative Splicing in NSCLC Cells

Collaborators (30)

Peter Hokland

Peter Meldgaard

Lars Aagaard

Tina Fuglsang Daugaard

Anders Etzerodt

Christoffer Trier Månsson

Clare Puttick

Johanne Lade-Keller

Rasmus Bak

Mikkel Carstensen

JAMES READING

Anne Grosboel Jensen

Marie Bill

Simone Stensgaard

Yonglun Luo

Eva Holm Greibe

Mette Nyegaard

Johannes Schmid

Hans Jürgen Hoffmann

Kristian Wiborg Antonsen

Signe Neldeborg

Maja Ludvigsen

Lene Niemann Nejsum

Magnus Stougaard

Søren Kragh Moestrup

Brage Storstein Andresen

Emil Aagaard Thomsen

Anders L. Nielsen

Zaigham Saghir

Christian Borbjerg Laursen

Make your next move.